Combined hypertensive medicines market warming up

Published: 2009-07-07 06:57:00
Updated: 2009-07-07 06:57:00
The domestic market of combined antihypertensive agents is gaining momentum with Korean leading manufacturers who see opportunities in the field.

Novartis Korea has pioneered the field with its Exforge in 2007 and garnered 17.7 billion won in last year’s sales.

Hanmi Pharm and Daewoong Phar...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.